Search

In Stock

Buy Cablivi (caplacizumab) Online

DISEASE INDICATIONS: Acquired thrombotic thrombocytopenic purpura (aTTP)

MANUFACTURER: Ablynx NV

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Cablivi, with its active ingredient caplacizumab, is a prescription medication used in the treatment of a rare and serious medical condition known as acquired thrombotic thrombocytopenic purpura (aTTP).

$4,125.96

Clear
Compare

Cablivi, with its active ingredient caplacizumab, is a prescription medication used in the treatment of a rare and serious medical condition known as acquired thrombotic thrombocytopenic purpura (aTTP). aTTP is an autoimmune disorder characterized by the formation of blood clots throughout the body, leading to a range of severe and life-threatening complications.

Here is a comprehensive description of Cablivi (caplacizumab):

1. Mechanism of Action: Cablivi is a novel therapeutic option that targets von Willebrand factor (vWF), a protein involved in blood clot formation. In aTTP, abnormal vWF levels can lead to excessive clotting. Cablivi works by inhibiting the interaction between vWF and platelets, preventing the formation of blood clots and reducing the risk of complications.

2. Indications: Cablivi is primarily indicated for use in adults experiencing an episode of acquired thrombotic thrombocytopenic purpura (aTTP) in combination with standard treatment. It is not used as a standalone treatment but as an adjunct to address the underlying blood clotting abnormalities associated with aTTP.

3. Administration: Cablivi is administered as a subcutaneous injection under the skin by healthcare professionals. The dosage and duration of treatment will be determined by a healthcare provider based on the individual patient’s needs and response to therapy.

4. Clinical Efficacy: Clinical trials have demonstrated that Cablivi can significantly reduce the time it takes to normalize platelet counts, decrease the recurrence of aTTP episodes, and improve overall outcomes in individuals with this rare disorder.

5. Side Effects: As with any medication, Cablivi may have potential side effects, including bleeding complications, headache, and an increased risk of bleeding in certain situations. It is essential for patients to discuss potential side effects and risks with their healthcare provider.

6. Monitoring: Patients receiving Cablivi require close monitoring of their platelet counts, bleeding symptoms, and overall response to treatment to ensure its effectiveness and safety.

7. Precautions: Cablivi should be used under the guidance of a healthcare professional, taking into consideration the patient’s medical history and potential interactions with other medications or medical conditions.

Cablivi represents an important advancement in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP), offering a targeted approach to managing the abnormal blood clotting associated with this rare and life-threatening disorder. It is a critical component of a comprehensive treatment plan that aims to improve the outcomes and quality of life for individuals affected by aTTP. Patients should work closely with their healthcare providers to determine the most appropriate treatment approach based on their specific needs and medical history.

Package

1 vial of 10 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Oxbryta (voxelotor) Online

$33,074.12
(0 Reviews)
ISEASE INDICATIONS: Sickle Cell Disease MANUFACTURER: Global Blood Therapeutics, Inc. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Oxbryta, known by its generic name Voxelotor, is a pharmaceutical medication used to treat a rare genetic blood disorder called sickle cell disease (SCD).

Buy Evrenzo (Roxadustat) Online

From $171.42
(0 Reviews)
DISEASE INDICATIONS: Anemia MANUFACTURER: Astellas Pharma Inc. FibroGen USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Pharmaceuticals and Medical Devices Agency (PMDA) Evrenzo, known by its generic name Roxadustat, is a pharmaceutical medication that belongs to a class of drugs called HIF-PH (Hypoxia-Inducible Factor Prolyl Hydroxylase) inhibitors. This innovative medication is primarily used to treat certain types of anemia, particularly those associated with chronic kidney disease (CKD) and inflammation.

Buy Givlaari (givosiran) Online

(0 Reviews)
DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Givlaari, known by its generic name Givosiran, is a pharmaceutical medication used to treat a rare genetic disorder called acute hepatic porphyria (AHP). This innovative medication represents a significant advancement in the management of this condition, which is characterized by recurrent, severe attacks of abdominal pain, neurological symptoms, and potential life-threatening complications.

Buy Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) Online

$24,063.64
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.

Buy Ondexxya (andexanet alfa) Online

$16,421.35
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ondexxya, known by its generic name Andexanet Alfa, is a medication used as a reversal agent for certain anticoagulant medications. It is primarily used in emergency situations when rapid reversal of the anticoagulant effects is necessary, particularly in cases of life-threatening bleeding or when invasive procedures are required.

Buy Accrufer (ferric maltol) Online

(0 Reviews)
DISEASE INDICATIONS: Iron deficiency MANUFACTURER: Shield Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Swissmedic (CH) Accrufer, with the generic name ferric maltol, is a prescription medication used in the treatment of iron deficiency anemia in adults. It is classified as an iron replacement therapy and is designed to help raise and maintain healthy levels of iron in the body.

Buy Feraccru (ferric maltol) Online

$162.85
(0 Reviews)
DISEASE INDICATIONS: Iron deficiency MANUFACTURER: Shield Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Swissmedic (CH) Feraccru, known by its generic name Ferric Maltol, is a pharmaceutical medication used to treat iron deficiency anemia in adult patients with inflammatory bowel disease (IBD). It is a novel oral iron replacement therapy designed to help replenish iron levels in individuals who have difficulty absorbing iron through their gastrointestinal system.

Back to Top
Product has been added to your cart